Carbamylation reduces the capacity of IgG for hexamerization and complement activation

Author(s):
Lubbers, R.; Oostindie, S.C.; Dijkstra, D.J.; Parren, P.W.H.I. (0000-0002-4365-3859); Verheul, M.K.; Abendstein, L. (0000-0001-7634-5353); Sharp, T.H.; Ru, A. de; Janssen, G.M.C.; Veelen, P.A. van (0000-0002-7898-9408); Bremer, E.T.J. van den; Bleijlevens, B.; Kreuk, B.J. de; Beurskens, F.J.; Trouw, L.A. (0000-0001-5186-2290)
Published
2020
Publication type
Article / Letter to editor
antibodiescomplementhumanrheumatoid arthritis
Date issued
2020-01-05
Language
English
Publisher
Oxford University Press
Is part of
Clinical and Experimental Immunology (2020), Vol. 200, no. 1, p. 1-11
hdl
1887/3181429
doi
10.1111/cei.13411
URL
https://academic.oup.com/cei/article/200/1/1/6402909